Antitrust regulators cleared the way on Friday for Amgen Inc.'s purchase of Immunex Corp., the biggest biotechnology merger ever. The Federal Trade Commission proposed an order that would allay antitrust concerns by making Immunex sell its cancer-fighting drug Leukine to Schering AG. Amgen and Immunex currently compete in the billion-dollar market for drugs that regenerate white blood cells.
July 16, 2002 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
Legalweek New York explores Business and Regulatory Trends, Technology and Talent drivers impacting law firms.
AMENDED NOTICE OF BANKRUPTCY JUDGE VACANCIES DISTRICT OF UTAH The United States Court of Appeals for the Tenth Circuit seeks applicati...
The New Jersey State Commission of Investigation (SCI) is seeking an experienced and visionary leader to serve as its next Executive Directo...
We are a boutique firm specializing the area of real estate law and handling both litigation and transactional matters. We are seeking an as...